For example, hyperglycemia has been shown to increase the chemoresistance of several prostate cancer cell lines to chemotherapy through the increase of histone H3 and H4 acetylation on the promoter region of insulin like growth factor binding protein 2 (IGFB2), a key player of prostate cancer progression (9). The gene discussed is IGFBP2; the disease is prostate carcinoma.